Bacterial coinfections with coronavirus disease 2019 (COVID-19).

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE
Published Date: Nov 10, 2021

Abstract

BACKGROUND: The pandemic caused by severe acute respiratory coronavirus virus 2 (SARS-CoV-2) has dramatically increased cheshospitalizations, and it is often difficult to determine whether there is a bacterial or fungal coinfection at time of presentation. In this study, we sought to determine the rates of coinfection and utilization of antibiotics in SARS-CoV-2 disease.

Authors

  • Glen Huang
    Division of Infectious Diseases, Department of Medicine, University of California - Los Angeles, Los Angeles, California.
  • Daisuke Furukawa
    Division of Infectious Diseases, Department of Medicine, University of California - Los Angeles, Los Angeles, California.
  • Bryant D Yang
    Division of Infectious Diseases, Department of Medicine, University of California - Los Angeles, Los Angeles, California.
  • Brian J Kim
    Department of Pharmacy, Olive View - University of California Los Angeles Medical Center, Sylmar, California.
  • Arthur C Jeng
    Division of Infectious Diseases, Department of Medicine, University of California - Los Angeles, Los Angeles, California.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals